These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10378765)

  • 1. Prevalence of Tourette syndrome.
    Millichap JG
    Dev Med Child Neurol; 1999 May; 41(5):356. PubMed ID: 10378765
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
    Pringsheim T
    J Psychiatry Neurosci; 2012 Nov; 37(6):432. PubMed ID: 23092593
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulants and tic disorders: from dogma to data.
    Castellanos FX
    Arch Gen Psychiatry; 1999 Apr; 56(4):337-8. PubMed ID: 10197828
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Jaworowski S; Benarroch F; Gross-Tsur V
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.
    Gadow KD; Sverd J
    J Dev Behav Pediatr; 1990 Oct; 11(5):269-71; discussion 272. PubMed ID: 1979565
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylphenidate role in Tourette syndrome prevalence.
    Millichap JG
    J R Soc Med; 1999 Mar; 92(3):156. PubMed ID: 10396274
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Prevalence of Tourette syndrome in a mainstream school population'.
    Traverse L
    Dev Med Child Neurol; 1998 Dec; 40(12):847-8. PubMed ID: 9881684
    [No Abstract]   [Full Text] [Related]  

  • 8. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.
    Robertson MM
    Eur Child Adolesc Psychiatry; 2006 Feb; 15(1):1-11. PubMed ID: 16514504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate.
    Krause KH; Dresel S; Krause J; Kung HF; Tatsch K; Lochmüller H
    J Neurol; 2002 Aug; 249(8):1116-8. PubMed ID: 12420715
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of attention-deficit-hyperactivity disorder.
    Elia J; Ambrosini PJ; Rapoport JL
    N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
    [No Abstract]   [Full Text] [Related]  

  • 11. Ritalin is okay for kids with both ADHD and Tourette's syndrome, study says.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Mar; 13(6):5-7. PubMed ID: 12449103
    [No Abstract]   [Full Text] [Related]  

  • 12. The stimulants.
    Wilens TE; Biederman J
    Psychiatr Clin North Am; 1992 Mar; 15(1):191-222. PubMed ID: 1347939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Priapism - side effect of methylphenidate].
    Aktuelle Urol; 2014 Mar; 45(2):94. PubMed ID: 24700059
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
    Levy F
    Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
    [No Abstract]   [Full Text] [Related]  

  • 15. Current issues in Tourette syndrome.
    Singer HS
    Mov Disord; 2000 Nov; 15(6):1051-63. PubMed ID: 11104186
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
    Hoekstra PJ; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055
    [No Abstract]   [Full Text] [Related]  

  • 17. The billion dollar business of being smart.
    Chinthapalli K
    BMJ; 2015 Sep; 351():h4829. PubMed ID: 26370589
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C
    Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of stimulant medications for ADHD.
    Natl Bur Econ Res Bull Aging Health; 2014; (1):1-2. PubMed ID: 25141389
    [No Abstract]   [Full Text] [Related]  

  • 20. Quillivant XR--an extended release oral suspension of methylphenidate.
    Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.